Active, not recruitingPHASE1, PHASE2NCT03597594
Haplocompatible Transplant Using TCRα/β Depletion Followed by CD45RA-Depleted Donor Lymphocyte Infusions for Severe Combined Immunodeficiency (SCID)
Studying T-B+ severe combined immunodeficiency due to gamma chain deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- St. Jude Children's Research Hospital
- Principal Investigator
- Ewelina Mamcarz, MDSt. Jude Children's Research Hospital
- Intervention
- Anti-thymocyte globulin (rabbit)(drug)
- Enrollment
- 4 enrolled
- Eligibility
- All sexes
- Timeline
- 2021 – 2028
Study locations (1)
- St. Jude Children's Research Hospital, Memphis, Tennessee, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03597594 on ClinicalTrials.govOther trials for T-B+ severe combined immunodeficiency due to gamma chain deficiency
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1, PHASE2NCT03538899Autologous Gene Therapy for Artemis-Deficient SCIDUniversity of California, San Francisco
- RECRUITINGPHASE1NCT03311503Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan ConditioningDavid Williams
- RECRUITINGNCT00055172Genetic Basis of ImmunodeficiencyNational Heart, Lung, and Blood Institute (NHLBI)
See all trials for T-B+ severe combined immunodeficiency due to gamma chain deficiency →